In a melanoma cell line model, it has been shown that mutant BRAF inhibition may increase DNA damage by downregulation of NHEJ pathway genes, including XRCC6, XRCC5, and PRKDC (Fatkhutdinov et al., 2016). The gene discussed is XRCC6; the disease is melanoma.